The DOI matches its Crossref record; 96 of the 96 references it cites were found in a registry or an index.
Oxidative Stress in the Progression of Alzheimer Disease in the Frontal Cortex
Open accessAbstract
We investigated oxidative stress in human postmortem frontal cortexfrom individuals characterized as mild cognitive impairment (n= 8), mild/moderate Alzheimer disease (n = 4), and late-stage Alzheimer disease (n = 9). Samples from subjects with no cognitive impairment (n = 10) that were age- and postmortem interval-matched with these cases were used as controls. The short postmortem intervalbrain samples were processed for postmitochondrial supernatant, nonsynaptic mitochondria, and synaptosome fractions. Samples were analyzed for several antioxidants (glutathione, glutathione peroxidase, glutathione reductase, glutathione-S-transferase, glucose-6-phosphate dehydrogenase, superoxide dismutase, catalase) and the oxidative marker, thiobarbituric acid reactive substances. The tissue was also analyzed for possible changes in protein damage using neurochemical markers for protein carbonyls, 3-nitrotyrosine, 4-hydroxynonenal, andacrolein. All 3 neuropil fractions (postmitochondrial supernatant, mitochondrial, and synaptosomal) demonstrated significant disease-dependent increases in oxidative markers. The highest changes were observed in the synaptosomal fraction. Both mitochondrial and synaptosomal fractions had significant declines in antioxidants (glutathione, glutathione peroxidase, glutathione-S-transferase, and superoxide dismutase). Levels of oxidative markers significantly correlated with Mini-Mental Status Examination scores. Oxidative stress was more localized to the synapses, with levels increasing in a disease-dependent fashion. These correlations implicate an involvement of oxidative stress in Alzheimer disease-related synaptic loss.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Moreover, TNT formation is often associated with oxidative stress, another key feature of AD [120,121,122].”
From The Impact of Neurotoxin Proteins Trafficked by Primary Cilia and Extracellular Vesicles in Neurodegenerative Diseases (2025) · cites this paper as [121]
Experimental — accuracy not yet measuredIn the citing paper
“3-nitrotyrosine and protein carbonyls, these last produced mainly by the action of free radicals on the peptide chain or by oxidation of amino acids, are used as biomarkers of oxidative damage in the brain of AD and MCI [18,24,31,32,33].”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [31]
In the citing paper
“In response to OS in the brain, a number of protective mechanisms are up regulated to maintain the oxidative balance, in particular compensatory induction of antioxidant enzymes such as superoxide dismutase, glutathione reductase, catalase have been found in vulnerable neurons in AD [31].”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [31]
In the citing paper
“Reduction of antioxidants such as glutathione, glutathione peroxidase, glutathione-S-transferase, and superoxide dismutase are demonstrated post-mortem in the mitochondrial and synaptosomal fractions in the frontal cortex of MCI and AD patients [31].”
From Role of Oxidative Damage in Alzheimer’s Disease and Neurodegeneration: From Pathogenic Mechanisms to Biomarker Discovery (2021) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029
Current concepts in mild cognitive impairment
Petersen, R. C., Doody, R., Kurz, A., Mohs, R. C., Morris, J. C., Rabins, P. V., Ritchie, K., Rossor, M., Thal, L., & Winblad, B. (2001) · Archives of Neurology · doi:10.1001/archneur.58.12.1985 · Cited by 4,781
Reactive Oxygen Species and the Central Nervous System
Halliwell, B. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10990.x · Cited by 2,947
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885
Mild Cognitive Impairment Represents Early-Stage Alzheimer Disease
Morris, J. C., Storandt, M., Miller, J. P., McKeel, D. W., Price, J. L., Rubin, E. H., & Berg, L. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.397 · Cited by 1,871
Halliwell, B. (2001) · Drugs & Aging · doi:10.2165/00002512-200118090-00004 · Cited by 1,502
Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo
Cirrito, J. R., Yamada, K. A., Finn, M. B., Sloviter, R. S., Bales, K. R., May, P. C., Schoepp, D. D., Paul, S. M., Mennerick, S., & Holtzman, D. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.10.028 · Cited by 1,265
Widespread Peroxynitrite-Mediated Damage in Alzheimer’s Disease
Smith, M. A., Richey Harris, P. L., Sayre, L. M., Beckman, J. S., & Perry, G. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-08-02653.1997 · Cited by 1,239
Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior
Selkoe, D. J. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.02.016 · Cited by 1,038
Cited by
Sorted by citations
Items 301–400 of 623
Thiamine Deficiency Induced Dietary Disparity Promotes Oxidative Stress and Neurodegeneration
Chauhan, A., Srivastva, N., & Bubber, P. (2017) · Indian Journal of Clinical Biochemistry · doi:10.1007/s12291-017-0690-1 · Cited by 29
Sandoval, K. E., Umbaugh, D. S., House, A., Crider, A. M., & WITT, K. A. (2019) · Neurochemical Research · doi:10.1007/s11064-019-02890-6 · Cited by 27
Mitochondria as a target for neuroprotection: implications for Alzheimer´s disease
Cardoso, S., Seiça, R. M. F., & Moreira, P. I. (2016) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2016.1205488 · Cited by 27
Duggal, P., & Mehan, S. (2019) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-190125 · Cited by 28
Mountaki, C., Dafnis, I., Panagopoulou, E. A., Vasilakopoulou, P. B., Karvelas, M., Chiou, A., Karathanos, V. Τ., & Chroni, A. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.05.022 · Cited by 28
Doped Graphene Quantum Dots as Biocompatible Radical Scavenging Agents
Bhaloo, A., Nguyen, S., Lee, B. H., Valimukhametova, A. R., González-Rodríguez, R., Sottile, O., Dorsky, A., & Naumov, A. V. (2023) · Antioxidants · doi:10.3390/antiox12081536 · Cited by 28
Zhang, Q., Su, G., Zhao, T., Sun, B., Zheng, L. P., & Zhao, M. (2019) · Journal of Functional Foods · doi:10.1016/j.jff.2019.103690 · Cited by 26
Sun, W., Cai, X., Wang, Z., Zhao, H., & Lan, M. (2020) · Microchemical Journal · doi:10.1016/j.microc.2020.104595 · Cited by 26
Differential relationships of NMDAR hypofunction and oxidative stress with cognitive decline
Lane, H., Wang, S., & Lin, C. (2023) · Psychiatry Research · doi:10.1016/j.psychres.2023.115288 · Cited by 25
Uddin, M. S., Mamun, A. A., Iqbal, M. A., Islam, A., Hossain, M. F., Khanum, S., & Rashid, M. (2016) · Advances in Alzheimer s Disease · doi:10.4236/aad.2016.53007 · Cited by 25
Hilt, S., Altman, R., Kálai, T., Maezawa, I., Gong, Q., Wachsmann‐Hogiu, S., Jin, L., & Voss, J. C. (2018) · Molecules · doi:10.3390/molecules23082010 · Cited by 25
Vitamin B12 Attenuates Changes in Phospholipid Levels Related to Oxidative Stress in SH-SY5Y Cells
Theiss, E. L., Griebsch, L. V., Lauer, A. A., Janitschke, D., Erhardt, V. K. J., Haas, E. C., Kuppler, K. N., Radermacher, J., Walzer, O., Portius, D., et al. (2022) · Cells · doi:10.3390/cells11162574 · Cited by 24
Bioavailability Study of an Innovative Orobuccal Formulation of Glutathione
Buonocore, D., Grosini, M., Giardina, S., Michelotti, A., Carrabetta, M. E., Seneci, A., Verri, M., Dossena, M., & Marzatico, F. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/3286365 · Cited by 24
Zamanian, M. Y., Kujawska, M., Nikbakhtzadeh, M., Hassanshahi, A., Ramezanpour, S., Kamiab, Z., & Bazmandegan, G. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666210506185042 · Cited by 24
Kandil, L. S., Farid, R. M., El-Gamal, S. S., & Hanafy, A. S. (2021) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2021.1934861 · Cited by 24
Tiwari, V., Mishra, A., Singh, S., & Shukla, S. (2023) · Current Alzheimer Research · doi:10.2174/1567205020666230605113856 · Cited by 24
Kan, H., Hu, W., Wang, Y., Wu, W., Yin, Y., Liang, Y., Wang, C., Huang, D., & Li, W. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3894 · Cited by 24
Oxidative Stress and Human Health
Hepel, M., & Andreescu, S. (2015) · ACS symposium series · doi:10.1021/bk-2015-1200.ch001 · Cited by 29
Aydın, E. P., Genç, A., Dalkıran, M., Uyar, E. T., Deniz, İ., Özer, Ö. A., & Karamustafalıoğlu, O. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.04.025 · Cited by 23
The Hidden Notes of Redox Balance in Neurodegenerative Diseases
Piccirillo, S., Magi, S., Preziuso, A., Serfilippi, T., Cerqueni, G., Orciani, M., Amoroso, S., & Lariccia, V. (2022) · Antioxidants · doi:10.3390/antiox11081456 · Cited by 26
Harish, G., Mahadevan, A., Bharath, M. M. S., & Shankar, S. K. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0907-x · Cited by 23
Shaik, J. B., Palaka, B. K., Penumala, M., Eadlapalli, S., Mark, M. D., Ampasala, D. R., Vadde, R., & Gangaiah, D. A. (2016) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12732 · Cited by 23
The Mitochondrion: A Potential Therapeutic Target for Alzheimer’s Disease
Lu, M., Zhao, X., Yao, P.-P., Xu, D.-E., & Ma, Q. (2018) · Neuroscience Bulletin · doi:10.1007/s12264-018-0310-y · Cited by 23
Ansari, M. A., Rao, M. S. R., & Al‐Jarallah, A. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1273626 · Cited by 23
Self-citationBurke, S. L., Cobb, J., Agarwal, R., Maddux, M., & Cooke, M. S. (2020) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-020-04611-3 · Cited by 22
Kara, J., Suwanhom, P., Wattanapiromsakul, C., Nualnoi, T., Puripattanavong, J., Khongkow, P., Lee, V. S., Gaurav, A., & Lomlim, L. (2019) · Archiv der Pharmazie · doi:10.1002/ardp.201800310 · Cited by 22
Kotarba, S., Kozłowska, M., Scios, M., Saramowicz, K., Barczuk, J., Granek, Z., Siwecka, N., Wiese, W., Golberg, M., Galita, G., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910797 · Cited by 24
Interference With Complex IV as a Model of Age-Related Decline in Synaptic Connectivity
Kriebel, M., Ebel, J., Battke, F., Griesbach, S., & Volkmer, H. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00043 · Cited by 21
Perspectives on the Tertiary Prevention Strategy for Alzheimer's Disease
Bu, X., Jiao, S., Lian, Y., & Wang, Y. (2015) · Current Alzheimer Research · doi:10.2174/1567205013666151215110114 · Cited by 20
Eteläinen, T. S., Kulmala, V., Svarcbahs, R., Jäntti, M. H., & Myöhänen, T. T. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.04.001 · Cited by 22
Ayyalasomayajula, N., Bandaru, L. J. M., Chetty, C. S., Dixit, P. K., & Challa, S. (2021) · Biological Trace Element Research · doi:10.1007/s12011-021-02959-w · Cited by 19
Pontrello, C. G., McWhirt, J., Glabe, C. G., & Brewer, G. J. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220824 · Cited by 20
Innovative pathological network‐based multitarget approaches for Alzheimer's disease treatment
Mayo, P., Pascual-Guerra, J., Crisman, E., Domínguez, C., López, M. G., & Leon, R. M. (2024) · Medicinal Research Reviews · doi:10.1002/med.22045 · Cited by 19
Stroh, M. A., Swerdlow, R. H., & Zhu, H. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.11.022 · Cited by 20
Aberrant Mitochondrial Metabolism in Alzheimer's Disease Links Energy Stress with Ferroptosis
Alves, F. M., Lane, D. J. R., Wahida, A., Jakaria, M., Kalinowski, P., Southon, A. G., Belaidi, A. A., Samperi‐Esteve, T., Nguyen, T. P. M., Peng, L., et al. (2025) · Advanced Science · doi:10.1002/advs.202504175 · Cited by 24
Neuroprotective Effects of Myrtenal in an Experimental Model of Dementia Induced in Rats
Dragomanova, S., Pavlov, S. P., Marinova, D., Hodzev, Y., Petralia, M., Fagone, P., Nicoletti, F., Lazarova, M., Tzvetanova, E., Alexandrova, A., et al. (2022) · Antioxidants · doi:10.3390/antiox11020374 · Cited by 20
Belkacemi, A., & Ramassamy, C. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150770 · Cited by 19
Akhtar, A., & Rahaman, S. B. (2025) · Brain Sciences · doi:10.3390/brainsci15080853 · Cited by 21
Gao, X., Li, Y., Sun, Z., Xu, H., Ma, G., Deng, Q., Zhang, C. X., & Li, R. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02313-0 · Cited by 18
Gamarra, D., Elcoroaristizabal, X., Martínez, M. F., & de Pancorbo, M. M. (2015) · Disease Markers · doi:10.1155/2015/746329 · Cited by 18
Zis, P., Strydom, A., Buckley, D., Adekitan, D., & McHugh, P. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.11.023 · Cited by 18
Burns, T. A., Westerman, T. L., Nuovo, G. J., Watts, M. R., Pettigrew, A., Yin, C., & Belknap, J. K. (2011) · Journal of Veterinary Internal Medicine · doi:10.1111/j.1939-1676.2011.0706.x · Cited by 19
Murakami, K., Shimizu, T., & Irie, K. (2011) · Journal of Amino Acids · doi:10.4061/2011/654207 · Cited by 18
Zhou, B., Li, J., Wu, A., Wang, X., Cheng, L., Yang, G., Gao, D., & Zhu, C. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1587986 · Cited by 18
Forqani, M. A., Akbarian, M., Amirahmadi, S., Soukhtanloo, M., Hosseini, M., & Forouzanfar, F. (2023) · International Journal of Neuroscience · doi:10.1080/00207454.2023.2257877 · Cited by 22
Research progress on ferroptosis in the pathogenesis and treatment of neurodegenerative diseases
Wang, L., Fang, X., Ling, B., Wang, F., Xia, Y., Zhang, W., Zhong, T., & Wang, X. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1359453 · Cited by 18
Oxidative stress precedes mitochondrial dysfunction in gerbil brain after aluminum ingestion
Vucetic-Arsic, S., Radonjić, N. V., Jovanović, M., Selaković, V., Nikolić, T., Velimirović, M., Stojković, T., Milovanović, A., Milovanovic, J. P., & Petronijević, N. (2013) · Environmental Toxicology and Pharmacology · doi:10.1016/j.etap.2013.10.008 · Cited by 18
Fronza, M. G., Baldinotti, R., Fetter, J., Sacramento, M., Sousa, F. S., Seixas, F., Collares, T., Alves, D., Praticò, D., & Savegnago, L. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00661 · Cited by 17
4-Hydroxynonenal Immunoreactivity Is Increased in the Frontal Cortex of 5XFAD Transgenic Mice
Shin, S.-W., Kim, D.-H., Jeon, W. K., & Han, J. (2020) · Biomedicines · doi:10.3390/biomedicines8090326 · Cited by 17
Neuroprotective Effects of Tripeptides—Epigenetic Regulators in Mouse Model of Alzheimer’s Disease
Khavinson, V. K., Ilina, A., Kraskovskaya, N., Linkova, N. S., Колчина, Н. В., Mironova, E. S., Erofeev, A., & Petukhov, M. (2021) · Pharmaceuticals · doi:10.3390/ph14060515 · Cited by 17
Neuroepigenetic Mechanisms of Action of Ultrashort Peptides in Alzheimer’s Disease
Ilina, A., Khavinson, V., Linkova, N. S., & Petukhov, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084259 · Cited by 18
Grosas, A. B., Kalimuthu, P., Smith, A. C., Williams, P. A., Millar, T. J., Bernhardt, P. V., & Jones, C. E. (2014) · Neurochemistry International · doi:10.1016/j.neuint.2014.03.002 · Cited by 17
Multidirectional inhibition of cortico-hippocampal neurodegeneration by kolaviron treatment in rats
Olajide, O. J., Asogwa, N. T., Moses, B. O., & Oyegbola, C. B. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-017-0012-6 · Cited by 16
Oxidation and ubiquitination in neurodegeneration
Riederer, B. M., Leuba, G., & ElHajj, Z. (2013) · Experimental Biology and Medicine · doi:10.1177/1535370213488484 · Cited by 16
Huerta‐Cervantes, M., Peña‐Montes, D. J., López‐Vázquez, M. A., Montoya-Pérez, R. D. C., Cortés‐Rojo, C., Olvera‐Cortés, M. E., & Saavedra‐Molina, A. (2021) · Nutrients · doi:10.3390/nu13051575 · Cited by 16
Lee, Y., Park, M.-C., Jeong, S. H., Kang, S. W., Baik, K., Jung, J. H., Lee, P. H., Sohn, Y. H., & Ye, B. S. (2021) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2021.05.003 · Cited by 18
Anupama, K. P., Antony, A., Olakkaran, S., Raghu, S. V., & Gurushankara, H. P. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02964-7 · Cited by 16
Research progress of ferroptosis in Alzheimer disease: A review
Han, Q., Sun, L., & Xiang, K. (2023) · Medicine · doi:10.1097/md.0000000000035142 · Cited by 16
Bir, A., Ghosh, A., Chauhan, A., Saha, S., Saini, A. K., Bisaglia, M., & Chakrabarti, S. (2024) · Antioxidants · doi:10.3390/antiox13030316 · Cited by 18
Singh, A., Verma, A., Bhardwaj, B., Saraf, P., Kumar, H., Jain, N., Waiker, D. K., Gajendra, T. A., Krishnamurthy, S., & Shrivastava, S. K. (2024) · ACS Omega · doi:10.1021/acsomega.3c10276 · Cited by 16
Cockayne, N. L., Duffy, S. L., Bonomally, R., English, A., Amminger, G. P., Mackinnon, A. J., Christensen, H. M., Naismith, S. L., & Hickie, I. B. (2015) · Trials · doi:10.1186/s13063-015-0762-6 · Cited by 17
Алексеевна, Г. М., Davydova, T. V., Кудрин, В. С., Wang, C., Narkevich, V. B., Morozova‐Roche, L. A., & Sewell, R. D. E. (2017) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.7b00379 · Cited by 17
Nam, S. M., Kim, J. W., Yoo, D. Y., Kim, W., Jung, H. Y., Choi, J. H., Hwang, I. K., Seong, J. K., & Yoon, Y. S. (2016) · Journal of Veterinary Science · doi:10.4142/jvs.2016.17.2.127 · Cited by 16
Zhang, C., Kuo, C., Moghadam, S. H., Monte, L., Rice, K. C., & Rissman, R. A. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-141722 · Cited by 17
Potential anti-Alzheimer’s disease activities of the roots of Desmodium caudatum
Guo, J., Feng, X., Zhou, S., Yan, W.-X., & Meng, D. (2016) · Industrial Crops and Products · doi:10.1016/j.indcrop.2016.06.018 · Cited by 16
Ansari, M. A., Rao, M. S. R., Al‐Jarallah, A., & Babiker, F. A. (2022) · Brain Research · doi:10.1016/j.brainres.2022.148134 · Cited by 15
Self-citationMandal, P. K., Dwivedi, D., Joon, S., Goel, A., Ahasan, Z., Maroon, J. C., Singh, P., Saxena, R., & Roy, R. G. (2023) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.3c00168 · Cited by 15
Ji, Y., Ni, X., Zheng, K., Jiang, Y., Ren, C., Zhu, H., Xiao, M., & Wang, T. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110747 · Cited by 17
Zhang, Q., Zhang, X., Yang, B., Li, Y., Sun, X., Li, X., Sui, P., Wang, Y., Tian, S., & Wang, C. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14460 · Cited by 15
Chen, H., Su, F., Ye, Q., Wang, Z., Shu, H., & Bai, F. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00131 · Cited by 15
Optimization of cell permeabilization in electron flow based mitochondrial function assays
Lei, X.-H., & Bochner, B. R. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.10.014 · Cited by 15
Proteomic identification of carbonylated proteins in 1,3-dinitrobenzene neurotoxicity
Steiner, S. R., & Philbert, M. A. (2011) · NeuroToxicology · doi:10.1016/j.neuro.2010.10.009 · Cited by 15
Wang, S., Cu, Y., Wang, C., Xie, W., Ma, L., Zhu, J., Zhang, Y., Dang, R., Wang, D., Wu, Y., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0143135 · Cited by 15
Dhull, D. K., & Kumar, A. (2017) · Inflammopharmacology · doi:10.1007/s10787-017-0431-3 · Cited by 15
Lichens of Parmelioid Clade as Promising Multitarget Neuroprotective Agents
Mansilla, V. S., González‐Burgos, E., Bermejo‐Bescós, P., Divakar, P. K., & Gómez-Serranillos, M. P. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00010 · Cited by 15
Glutathione S-transferases variants as risk factors in Alzheimer’s disease
Wang, T. (2015) · Neurological Sciences · doi:10.1007/s10072-015-2245-7 · Cited by 15
Sheng, J., Wu, S., Zhang, Q., Li, Z., & Huang, H. (2022) · IEEE Access · doi:10.1109/access.2022.3186888 · Cited by 18
Martínez, M. (2023) · Antioxidants · doi:10.3390/antiox12071373 · Cited by 14
Gangarde, P., Bhatt, S., & Pujari, R. (2025) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2025.127612 · Cited by 14
de Mendonca, E., Alcalá, E. S., & Fernández‐Mestre, M. (2014) · Neurología · doi:10.1016/j.nrl.2014.10.012 · Cited by 14
Tripathi, S., & Mazumder, P. M. (2021) · Drug Development Research · doi:10.1002/ddr.21849 · Cited by 14
Hyun, D., & Lee, J. (2021) · Antioxidants · doi:10.3390/antiox11010007 · Cited by 15
Natural Compounds (Small Molecules) as Potential and Real Drugs of Alzheimer's Disease
Cahlíková, L., Macáková, K., Benešová, N., Chlebek, J., Hošťálková, A., & Opletal, L. (2014) · Studies in natural products chemistry · doi:10.1016/b978-0-444-63281-4.00006-9 · Cited by 14
Piccirillo, S., Preziuso, A., Amoroso, S., Serfilippi, T., Miceli, F., Magi, S., & Lariccia, V. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01187-y · Cited by 13
Honey and Alzheimer’s Disease—Current Understanding and Future Prospects
Shaikh, A., Ahmad, F., Teoh, S. L., Kumar, J., & Yahaya, M. F. (2023) · Antioxidants · doi:10.3390/antiox12020427 · Cited by 19
Dimiza, F., Barmpa, A., Chronakis, A., Hatzidimitriou, A. G., Sanakis, Y., Papadopoulos, A. N., & Psomas, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076391 · Cited by 13
Hu, Z., Yuan, Y.-Q., Tong, Z., Liao, M., Yuan, S., Jian, Y., Yang, J.-L., & Liu, W. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03529-y · Cited by 13
Babaei, F., Navidi-Moghaddam, A., Naderi, A., Ghafghazi, S., Mirzababaei, M., Dargahi, L., Mohammadi, G., & Nassiri‐Asl, M. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e30426 · Cited by 13
Harish, G., Venkateshappa, C., Mahadevan, A., Pruthi, N., Bharath, M. M. S., & Shankar, S. K. (2012) · Biopreservation and Biobanking · doi:10.1089/bio.2012.0001 · Cited by 13
Antioxidant and neuroprotective effects of mGlu3 receptor activation on astrocytes aged in vitro
Turati, J., Ramírez, D., Carniglia, L., Saba, J., Caruso, C. M., Quarleri, J. F., Durand, D., & Lasaga, M. (2020) · Neurochemistry International · doi:10.1016/j.neuint.2020.104837 · Cited by 13
Topalis, V., Voros, C., & Ziaka, M. (2025) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/08919887251361578 · Cited by 14
Rezk, S., Lashen, S., El‐Adl, M., Elshopakey, G. E., Elghareeb, M. M., Hendam, B. M., Caceci, T., Cenciarelli, C., & Marei, H. E. S. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-021-00890-6 · Cited by 12
RetractedJiyah, A., Muhammad, S. A., Ibrahim, A., Bulama, I., Ibrahim, A., Abbas, A. Y., Imam, M. U., Saidu, Y., & Bilbis, L. S. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105618 · Cited by 13
Ngah, W. Z. W., Ahmad, H. F., Ankasha, S. J., Makpol, S., & Tooyama, I. (2024) · Antioxidants · doi:10.3390/antiox13121504 · Cited by 12
Transcriptomic signatures of oxytosis/ferroptosis are enriched in Alzheimer’s disease
Currais, A. J. M., Sanchez, K. L., Soriano‐Castell, D., Dar, N. J., Evensen, K. G., Soriano, S., & Maher, P. A. (2025) · BMC Biology · doi:10.1186/s12915-025-02235-6 · Cited by 14
Ramos, E., Romero, A., Marco, J. L., & del Pino, J. (2016) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12590 · Cited by 12
Nanomaterials for neurodegenerative diseases: Molecular mechanisms guided design and applications
Li, T., Hou, X., Yu, Q., Duan, X., Yan, P., Zhu, H., Xie, Z., & Zhang, H. (2021) · Nano Research · doi:10.1007/s12274-021-3865-2 · Cited by 12
Applications of nanodiamonds in the diagnosis and treatment of neurological diseases
Tang, G. F., Zhang, M. R., Liu, Q., Tian, X., & R., R. (2022) · Journal of Nanoparticle Research · doi:10.1007/s11051-022-05434-2 · Cited by 13
The Role of AMP-activated Protein Kinase in Oxytosis/Ferroptosis: Protector or Potentiator?
Currais, A. J. M., Kepchia, D., Liang, Z., & Maher, P. A. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0013 · Cited by 12
Role of Lipid Peroxidation Process in Neurodegenerative Disorders
Muthuraman, A., Rishitha, N., Paramakrishnan, N., Bhaskaran, M., & Ramesh, M. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.81188 · Cited by 12
Metadata
- Authors
- Ansari, M. A., & Scheff, S. W.
- Affiliations
- University of Kentucky (US)
- Corresponding author
- Scheff, Stephen W.
- ORCID
- Ansari, Mubeen A.
- Venue
- Journal of Neuropathology & Experimental Neurology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-02
- Volume
- 69
- Issue
- 2
- Pages
- 155-167
- ISSN
- 0022-3069 (ISSN-L)
- 1554-6578
- PMC
- PMC2826839
- OpenAlex
- W2031762170
- Cited by
- 605
- References
- 96
- Citations by year
- 2026: 29 · 2025: 38 · 2024: 44 · 2023: 40 · 2022: 51 · 2021: 56 · 2020: 44 · 2019: 38 · 2018: 30 · 2017: 31 · 2016: 41 · 2015: 29 · 2014: 31 · 2013: 24 · 2012: 31
- FWCI
- 21.61
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Neuropathology & Experimental Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute on Aging (AG-028383, AG27219, P30AG028383, P01AG014449, R01AG043375, R01AG027219)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- oxidative stress, Alzheimer's disease, frontal cortex, synaptosomes, mitochondria, antioxidants, glutathione, superoxide dismutase, lipid peroxidation, protein carbonyls, nitrotyrosine, 4-hydroxynonenal, acrolein, synaptic loss, disease progression, mild cognitive impairment, postmortem brain
- MeSH terms
- Aged, Aged, 80 and over, Aldehydes, Alzheimer Disease, Antioxidants, Female, Frontal Lobe, Humans, Male, Mental Status Schedule, Synapses, Tissue Distribution, Tyrosine, Biomarkers, Thiobarbituric Acid Reactive Substances, Oxidative Stress, Disease Progression, Protein Carbonylation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review